Tvardi Therapeutics, Inc. (TVRD) earnings · rev $7.1M
These earnings events as JSON? API free 100/dayTvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
This TVRD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $10.0M.
When the next TVRD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 66.0% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TVRD research stays on the stock page; the tape stays on the quote page.
TVRD earnings FAQ
What are TVRD's latest revenue and net income?
Latest cached Tvardi Therapeutics, Inc. (TVRD) revenue for Dec 31, 2024 was $7.1M. Net income was -$70.9M. Statements: https://lician.com/financials/tvrd
What is TVRD's latest diluted EPS?
Latest cached Tvardi Therapeutics, Inc. (TVRD) diluted EPS for Dec 31, 2024 was -$15.53.
What period does the latest TVRD earnings print cover?
The latest cached Tvardi Therapeutics, Inc. (TVRD) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
How did TVRD revenue change from the prior cached period?
Cached Tvardi Therapeutics, Inc. (TVRD) revenue was down 66.0% from $21.0M (Dec 31, 2023) to $7.1M (Dec 31, 2024). Statements: https://lician.com/financials/tvrd
Where are TVRD earnings listed?
Cached earnings facts for Tvardi Therapeutics, Inc. (TVRD) are listed at https://lician.com/earnings/tvrd. Statements: https://lician.com/financials/tvrd
Not investment advice.